Literature DB >> 10577750

Emerging role of nitric oxide in cancer.

P A Brennan1, I P Downie, J D Langdon, G A Zaki.   

Abstract

The small molecule nitric oxide has generated an exponential amount of research since its identification as a biological messenger in 1987. It is a free radical, the actions of which are diverse, and many are still poorly understood. An area of great interest is the role of nitric oxide in the growth and metastasis of solid tumours, where it seems to have a complex action including both inhibitory and tumour-promoting activity. Over 28,000 research papers have been written on nitric oxide, with only a minority concentrating on the head and neck. In this review, we give a brief history of this fascinating molecule, concentrating on its possible interest to oral and maxillofacial surgeons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577750     DOI: 10.1054/bjom.1999.0201

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  4 in total

1.  Schizandrin B protects LPS-induced sepsis via TLR4/NF-κB/MyD88 signaling pathway.

Authors:  Jianjun Xu; Caijiao Lu; Zhengjun Liu; Peng Zhang; Hailei Guo; Tingting Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 2.  Nitrosothiol signaling and protein nitrosation in cell death.

Authors:  Anand Krishnan V Iyer; Yon Rojanasakul; Neelam Azad
Journal:  Nitric Oxide       Date:  2014-07-23       Impact factor: 4.427

3.  Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia.

Authors:  Cléber Sergioda da Silva; Marcia Antoniazi Michelin; Renata Margarida Etchebehere; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

4.  Anti-Inflammatory Effect of Piper attenuatum Methanol Extract in LPS-Stimulated Inflammatory Responses.

Authors:  You Jin Kim; Jeong Deok; Sunggyu Kim; Deok Hyo Yoon; Gi-Ho Sung; Adithan Aravinthan; Seungihm Lee; Mi-Nam Lee; Suntaek Hong; Jong-Hoon Kim; Young-Jin Son; Jae Youl Cho
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-25       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.